A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(3 sites)

United States

Center for Clinical and Cosmetic Research, Aventura, Florida

Moore Clinical Research, Inc., Brandon, Florida

Center for Clinical Studies, LTD. LLP, Webster, Texas